Sonoporation-mediated transduction of siRNA ameliorated experimental arthritis using 3 MHz pulsed ultrasound (Q44620776)

4 December 2017

title

Sonoporation-mediated transduction of siRNA ameliorated experimental arthritis using 3 MHz pulsed ultrasound (English)

1 reference

4 December 2017

11

Hiroyoshi Fujiwara

1 reference

4 December 2017

Hiroaki Inoue

1

1 reference

4 December 2017

Yuji Arai

2

1 reference

4 December 2017

Tsunao Kishida

3

1 reference

4 December 2017

Masaharu Shin-Ya

4

1 reference

4 December 2017

Ryu Terauchi

5

1 reference

4 December 2017

Shuji Nakagawa

6

1 reference

4 December 2017

Masazumi Saito

7

1 reference

4 December 2017

Shinji Tsuchida

8

1 reference

4 December 2017

Atsuo Inoue

9

1 reference

4 December 2017

Toshiharu Shirai

10

1 reference

4 December 2017

Osam Mazda

12

1 reference

4 December 2017

Toshikazu Kubo

13

1 reference

4 December 2017

publication date

11 November 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

54

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

874-881

1 reference

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Cell and cytokine imbalances in rheumatoid synovitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Osteoclasts are essential for TNF-alpha-mediated joint destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

The problem of choice: current biologic agents and future prospects in RA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

RNA interference targeting Fas protects mice from fulminant hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

RNA Interference Advances to Early-Stage Clinical Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Nonviral approach for targeted nucleic acid delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Electro-transfer of small interfering RNA ameliorated arthritis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Comparison of anti-rheumatic effects of local RNAi-based therapy in collagen induced arthritis rats using various cytokine genes as molecular targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Small interfering RNA targeting CD81 ameliorated arthritis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Silencing the expression of connexin 43 decreases inflammation and joint destruction in experimental arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

The effect of continuous ultrasound on chronic non-specific low back pain: a single blind placebo-controlled randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Artificial cavitation nuclei significantly enhance acoustically induced cell transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Enhanced retroviral gene delivery in ultrasonic standing wave fields

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Use of ultrasound to enhance nonviral lung gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Tumor necrosis factor inhibitors for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: A role for scintigraphy with99mTc-infliximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Local infusion of infliximab for the treatment of acute joint inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRAS.2013.10.021

10.1016/J.ULTRAS.2013.10.021

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference